35 related articles for article (PubMed ID: 10561914)
1. Early lymphocyte reconstitution and viral infections in adolescents and adults transplanted for sickle cell disease.
Vasseur L; Cuffel A; Pondarré C; Dalle JH; Chevillon F; Fourmont AM; Flamarion E; Yakouben K; Guérin-El Khourouj V; Morin F; Ibanez C; Peffault de Latour R; Boissel N; Arlet JB; Moins-Teisserenc H; Caillat-Zucman S; Dhédin N
Bone Marrow Transplant; 2024 May; 59(5):708-710. PubMed ID: 38413822
[No Abstract] [Full Text] [Related]
2. Virus reactivation in high-risk non-Hodgkin's lymphoma patients after autologous CD34+ -selected peripheral blood progenitor cell transplantation.
Lin PC; Lee MY; Lin JT; Hsiao LT; Chen PM; Chiou TJ
Int J Hematol; 2008 May; 87(4):434-439. PubMed ID: 18317882
[TBL] [Abstract][Full Text] [Related]
3. Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
De Rosa L; Anghel G; Pandolfi A; Riccardi M; Amodeo R; Majolino I
Int J Hematol; 2004 Jan; 79(1):85-91. PubMed ID: 14979484
[TBL] [Abstract][Full Text] [Related]
4. CD34+-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: increased risk of infectious complications.
Maeda S; Kagami Y; Ogura M; Taji H; Suzuki R; Kondo E; Asakura S; Takeuchi T; Miura K; Ando M; Nakamura S; Ito T; Kinoshita T; Ueda R; Morishima Y
Int J Hematol; 2001 Aug; 74(2):214-21. PubMed ID: 11594525
[TBL] [Abstract][Full Text] [Related]
5. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
6. A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.
Gandhi M; Jestice H; Scott M; Bloxham D; Bass G; Craig J; Marcus R
Bone Marrow Transplant; 1999 Aug; 24(4):369-75. PubMed ID: 10467325
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J
Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
[TBL] [Abstract][Full Text] [Related]
10. Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation.
Takeshima M; Takamatsu H; Iida M; Mochizuki Y; Okumura H; Yoshida T
Int J Hematol; 1999 Oct; 70(3):193-9. PubMed ID: 10561914
[TBL] [Abstract][Full Text] [Related]
11. Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation.
Lanza F; Campioni DC; Hellmann A; Milone G; Wahlin A; Walewski J; Spedini P; Fiamenghi C; Cuneo A; Knopińska W; Swierkowska-Czeneszew M; Petriz J; Fruehauf S; Farge D; Mohty M; Passweg J; Ruuto T; Madrigal A; Johnsen HE;
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1670-6. PubMed ID: 23988403
[TBL] [Abstract][Full Text] [Related]
12. CD34+ CD90+ cells and late hematopoietic reconstitution after autologous peripheral blood stem cell transplantation.
Shimazaki C; Sumikuma T; Inaba T
Leuk Lymphoma; 2004 Apr; 45(4):661-8. PubMed ID: 15160937
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
